Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Common drug review"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"700 - The arts; fine & decorative arts"
Search alternatives
:
common drug »
common due
Showing
1
-
20
of
76
Search:
'"Common drug review"'
,
query time: 0.09s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
2
Tocilizumab (Actemra) : adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
3
Golimumab (Simponi) IV : in combination with methotrexate (MTX) for the treatment of adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
4
Eplerenone (Inspra) (25 mg tablet and 50 mg tablet) : as an adjunct to standard therapy to reduce the risk of cardiovascular mortality and hospitalization for heart failure in pati...
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
5
Eplerenone (Inspra) (25 mg tablet and 50 mg tablet) : as an adjunct to standard therapy to reduce the risk of cardiovascular mortality and hospitalization for heart failure in pati...
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
6
Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
7
Ustekinumab (Stelara) injection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
8
Ustekinumab (Stelara) injection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
9
Golimumab (Simponi) IV : in combination with methotrexate (MTX) for the treatment of adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
10
Tocilizumab (Actemra) : adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
11
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
12
Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
13
Pharmacoeconomic review report: Rivaroxaban (Xarelto) (Bayer Inc.) : indication : in combination with 75 mg to 100 mg acetylsalicylic acid (ASA), for the prevention of stroke, myoc...
Published 2019
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
14
Clinical review report: Rivaroxaban (Xarelto) Bayer Inc. : indication : in combination with 75 mg to 100 mg acetylsalicylic acid, for the prevention of stroke, myocardial infarctio...
Published 2019
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
16
Clinical review report: Riociguat (Adempas)
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
17
Clinical review report: Riociguat (Adempas)
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
18
Pharmacoeconomic review report: Upadacitinib (Rinvoq) (AbbVie) : indication: for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an ina...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
20
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
1
2
3
4
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 700 - The arts; fine & decorative arts
Year of Publication
From:
To:
Classification
700 - The arts; fine & decorative arts
610 - Medicine & health
27
140 - Specific philosophical schools
23
330 - Economics
19
Language
English
76
Collection
National Center for Biotechnology Information
76
Author
Canadian Agency for Drugs and Technologies in Health
71
CADTH Canadian Drug Expert Committee
17
Canadian Diabetes Association
2
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22700+-+The+arts%3B+fine+%26+decorative+arts%22&lookfor=%22Common+drug+review%22&type=Series
Send by Email
×
Loading...